Morbidity and mortality patterns in small-for-gestational age infants born preterm

Vasileios Giapros1, Aikaterini Drougia, Nikolaos Krallis

  • 1Neonatal Intensive Care Unit, University Hospital of Ioannina, Ioannina, Greece. vgiapros@cc.uoi.gr

Insights

Premature infants who are small-for-gestational age (SGA) face higher risks of chronic lung disease (CLD) and death compared to appropriate-for-gestational age (AGA) infants. This highlights critical differences in outcomes for preterm infants based on growth metrics.

Area of Science:

  • Neonatalogy
  • Perinatology
  • Pediatric Critical Care

Background:

  • Premature neonates born small-for-gestational age (SGA) may experience greater adverse effects than those born appropriate-for-gestational age (AGA).
  • Understanding the comparative morbidity and mortality in these groups is crucial for optimizing neonatal care.

Purpose of the Study:

  • To compare the morbidity and mortality rates between SGA and AGA neonates born with low gestational age (GA).
  • To identify specific risks associated with SGA status in preterm infants.

Main Methods:

  • A 9-year study of preterm infants (GA 24-31 weeks) hospitalized in a neonatal intensive care unit (NICU).
  • Assessment of SGA status association with neonatal death and major morbidities including CLD, IVH, ROP, NEC, RDS, PDA, and sepsis.
  • Multiple logistic regression analysis was employed to evaluate these associations.

Main Results:

  • Small-for-gestational age (SGA) neonates showed a significantly higher incidence of chronic lung disease (CLD) (57.1% vs 29.3%).
  • Mortality rates were substantially higher in SGA neonates (33.3% vs 17% for AGA), particularly in subgroups (24.1% vs 6.3% for GA 28-31 weeks).
  • SGA status was independently associated with increased mortality (OR 3.4) and CLD (OR 3.9) in logistic regression.

Conclusions:

  • Small-for-gestational age (SGA) neonates born between 24-31 weeks GA face elevated risks for developing chronic lung disease (CLD).
  • Neonatal death risk is significantly higher in SGA preterm infants compared to AGA preterm infants of similar gestational age.
Abstract

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...